Mythology,

Dr. G is a clever scientist and aware of his competition. IMO, he was trying to do too much at Cardio with both Luxsphere and the Diagnostics development. I think, had he focussed solely on the diagostic clinical trials, and left the development of the Luxsphere with Merck and others on the shelf, he would of had sufficient funds for the trials of the Diagnostics. The positive trials, would then fuel his other endeavours with Luxspheres.

Gameson, I do not know exactly what the technology of the competition is, and I would think it is not the same as cardio as they have Intellectual Property. However, the competition is also developing a point-of care diagnostic to detect the Tropinone level for patients as a sign of Heart Issues. This is what Cardio is doing !